Proposed model: Mechanisms of immunomodulation induced by probiotic bacteria

Clinical and Vaccine Immunology

Volumn 14, Issue 5, 2007, Pages 485-492

  Maldonado Galdeano, C ^a,b   De Moreno De Leblanc, A ^a,b   Vinderola, G ^a   Bibas Bonet, M E ^b   Perdigon G ^a,b  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; TOLL LIKE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; BIFIDOBACTERIUM; DRUG MECHANISM; ENTEROPATHY; FOOD ALLERGY; HUMAN; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; INTESTINE FLORA; LACTOBACILLUS; LACTOCOCCUS; MICROBIAL COLONIZATION; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SHORT SURVEY; STREPTOCOCCUS; ANIMAL; BACTERIUM; BIOLOGICAL MODEL; EPITHELIUM CELL; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MUCOSA; REVIEW;

ANIMALS; BACTERIA; EPITHELIAL CELLS; HUMANS; INTESTINES; MODELS, IMMUNOLOGICAL; MUCOUS MEMBRANE; PROBIOTICS;

EID: 34250310030     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00406-06     Document Type: Short Survey

References (92)

1. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-680.
2. Alander, M., R. Satokari, R. Korpela, M. Saxelin, T. Vilpponen-Salmela, T. Mattila-Sandholm, and A von. Wright. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Env. Microbiol. 65:351-354.
3. Axelsson, L. T., T. C. Chung, W. G. Dobrogosz, and S. E. Lindgren. 1989. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb. Ecol. Health Dis. 2:131-136.
4. Berg, R. D. 1998. Probiotic, probiotics or 'conbiotics'? Trends Microbiol. 6:89-92.
5. Bernet, M. F., D. Brassart, J. R. Neeser, and A. L. Servin. 1993. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl. Environ. Microbiol. 59:4121-4128.
6. Bernet-Camard, M. F., V. Lievin, D. Brassart, J. R. Neeser, A. L. Servin, and S. Hudault. 1997. The human Lactobacillus acidophilus strain LA1 secretes nonbacteriocin antibacterial substances active in vitro and in vivo. Appl. Environ. Microbiol. 63:2747-2753.
7. Bibiloni, R., R. N. Fedorak, J. W. Tannock, K. L. Madsen, P. Gionchetti, M. Campieri, C. De Simone, and R. Balfour Sarpor. 2005. DSL #3 probioticsmisture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100:1539-1546.
8. Cario, E., G. Gerken, and D. K. Podolsky. 2004. Toll-like receptor-2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127:224-238.
9. Coconnier, M. H., M. F. Bernet, S. Kerneis, G. Chauviere, J. Fourniat, and A. L. Servin. 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett. 110:299-305.
10. Coconnier, M. H., T. R. Klaenhammer, S. Kerneis, M. F. Bernet, and A. L. Servin. 1992. Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture. Appl. Environ. Microbiol. 58:2034-2039.
11. Coconnier, M. H., V. Levien, E. Hemery, and A. L. Servin. 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64:4573-4580.
12. Cooffman, R. L., D. Lebman, and B. Shrader. 1989. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170:1039-1044.
13. Dembele, T., V. Obdrzalek, and M. Votava. 1998. Inhibition of bacterial pathogens by lactobacilli. Zentralbl. Bakteriol. 288:395-401.
14. de Moreno de LeBlanc, A., and G. Perdigón. 2004. Yoghurt feeding inhibits promotion and progression of experimental colorectal cancer. Med. Sci. Monit. 10:96-104.
15. de Moreno de LeBlanc, A., C. Maldonado Galdeano, S. Chaves, and G. Perdigón. 2005. Oral administration of L. casei CRL 431 increases immunity in bronchus and mammary glands. Eur. J. Inflamm. 3:23-28.
16. de Moreno de LeBlanc, A., C. Matar, E. Farnworth, and G. Perdigón. 2006. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine 34:1-8.
17. de Moreno de LeBlanc, A., C. Matar, N. LeBlanc, and G. Perdigón. 2005. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 7:477-486.
18. de Moreno de LeBlanc, A., J. Valdez, and G. Perdigón. 2004. Regulatory effect of yoghurt on intestinal inflammatory immune response. Eur. J. Inflamm. 2:21-61.
19. de Vrese, M., A. Stegelmann., B. Ritcher, S. Fenselau, C. Laue, and J. Schrezenmeir. 2001. Probiotics: compensation for lactase insufficiency. Am. J. Clin. Nutr. 73:S421-S429.
20. Di Giacinto, C., M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J. Immunol. 174:3237-3246.
21. Dogi, C. A., and G. Perdigón. 2006. Importance of the host specificity in the selection of probiotic bacteria. J. Dairy Res. 73:357-366.
22. Finegold, M. V., L. Sutter, and G. E. Mathisen. 1983. Normal indigenous intestinal flora, p. 3-31. In D. J. Hentges (ed.), Human intestinal microflora in health and disease. Academic Press, New York, NY.
23. Fukushima, M., and M. Nakano. 1996. Effects of a mixture of organisms Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on fat-and-cholesterol-enriched diet. Br. J. Nutr. 76:857-867.
24. Fukushima, Y., Y. Kawata, H. Hara, A. Terada, and T. Mitsuoka. 1998. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol. 42:39-44.
25. Fuller, R. 1989. Probiotics in man and animals. J. Appl. Bacteriol. 66:365-369.
26. Fuller, R. 1991. Probiotics in human medicine. Gut 32:439-442.
27. Furrie, E., S. Macfarlane, A. Kennedy, J. H. Cummings, S. V. Walsh, D. A. O'Neil, and G. T. Macfarlane. 2005. Synbiotic therapy (Bifidobacterium longum/Sinergy) initiates resolution of inflammation in patients with active ulcerative colitis: a randomized controlled pilot trial. Gut 54:242-249.
28. Gill, H. S., K. J. Rutherfurd, J. Prasad, and P. K. Gopal. 2000. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83:167-176.
29. Granato, D., F. Perotti, I. Masserey, M. Rouvet, M. Golliard, A. Servin, and D. Brassart. 1999. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1to human enterocyte-like Caco-2 cells. Appl. Environ. Microbiol. 65:1071-1077.
30. Greene, J. D., and T. R. Klaenhammer. 1994. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 60:4487-4494.
31. Herías, M. V., J. F. J. G. Koninkx, J. G. Vos, J. H. J. Huis in't Veld, and J. E. van Dijk. 2005. Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. Int. J. Food Microbiol. 103:143-155.
32. Hermelijn, H. S., A. Engering, D. van der Kleij, E. C. de Jong, K. Schip perd, T. M. M. van Capela, B. A. J. Zaat, M. Yazdanbakhsh, E. A. Wierenga, Y. van Kooyk, and M. L. Kapsenberg. 2005. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115:1260-1267.
33. Hirayama, K., and J. Rafter. 1999. The role of lactic acid bacteria in colon cancer prevention: mechanistic considerations. Antonie Leeuwenhoek 76: 391-394.
34. Husband, A. J., and J. L. Cowans. 1978. The origin and antigen dependent distribution of IgA-containing cells in the intestine. J. Exp. Med. 148:1146-1160.
35. Ishikawa, H., I. Akedo, T. Otani, T. Suzuki, T. Nakamura, I. Takeyama, S. Ishiguro, E. Miyaoka, T. Sobue, and T. Kakizoe. 2005. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 116:762-767.
36. Isolauri, E., Y. Sütas, P. Kankaanpää, H. Arvilommi, and S. Salminen. 2001. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73:444S-450S.
37. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptative immune response. Nat. Immunol. 5:987-995.
38. Janeway, C. A., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
39. Jang, M. H., M.-N. Kweon, K. Iwatani, M. Yamamoto, K. Terahara, Ch. Sasakawa, T. Suzuki, T. Nochi, Y. Yokota, P. D. Rennert, T. Hiroi, H. Tamagawa, H. Iijima, J. Kunisawa, Y. Yuki, and H. Kiyono. 2004. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA 101:6110-6115.
40. Kato, I., K. Tanaka, and T. Yokokura. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes. Int. J. Immunopharmacol. 21:121-131.
41. Kelly, D., S. Conway, and R. Aminov. 2005. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. 26:326-333.
42. Kopp-Hoolihan, L. 2001. Prophylactic and therapeutic uses of probiotics: a review. J. Am. Diet. Assoc. 101:229-238.
43. Krahenbuhl, J. P., and M. R. Neutra. 2000. EpithelialMcells: differentiation and function. Annu. Rev. Cell Dev. Biol. 16:301-332.
44. Kunimoto, D. Y., R. P. Nordan, and W. Strober. 1989. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J. Immunol. 143:2230-2235.
45. Lamm, M. 2003. IgA function. Mucosal Immunol. Update 11:7-8.
46. Lee, S. J., S. Evers, D. Roeder, A. F. Parlow, J. Risteli, L. Risteli, Y. C. Lee, T. Feizi, H. Langen, and M. C. Nussenzweig. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898-1901.
47. Maassen, C., C. van Holten-Neelen, F. Balk, M. Heijne den Bak-Glashouwer, R. Leer, J. Laman, W. Boersma, and E. Claassen. 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613-2623.
48. Macpherson, A. J., and N. L. Harris. 2004. Interaction between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4:478-485.
49. Macpherson, A. J., and T. Uhr. 2004. Compartmentalization of the mucosal immune response to commensal intestinal bacteria. Ann. N. Y. Acad. Sci. 1029:36-43.
50. Macpherson, A. J., and T. Uhr. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303:1662-1665.
51. Majamaa, H., and E. Isolauri. 1997. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99:179-185.
52. Maldonado Galdeano, C., and G. Perdigón. 2004. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol. 97:673-681.
53. Maldonado Galdeano, C., and G. Perdigón. 2005. The probiotic bacteria Lactobacillus casei induces activation of the gut mucosal immune system through the innate immunity. Clin. Vaccine Immunol. 13:219-226.
54. Miettinen, M., S. Matikainen, J. Vuopio-Varkila, and K. Varkila. 1996. Production of tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64:5403-5405.
55. Miettinen, M., J. Vuopio-Varkila, J. Pirhonen, K. Varkila, M. Korimoto, and I. Julkunen. 1998. Lactobacilli and streptococci induce interleukin 12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun. 66:6058-6062.
56. Milling, S. W. F., L. Cousins, and G. MacPherson. 2005. How do dendritic cells interact with intestinal antigens? Trends Immunol. 26:349-352.
57. Mowat, A. M. 2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331-341.
58. Naidu, A. S., W. R. Bidlack, and R. A. Clemens. 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit. Rev. Food Sci. Nutr. 39:13-126.
59. Netea, M. G., C. van der Graaf, J. W. M. Van der Meer, and B. Jan Kullberg. 2004. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 75:749-755.
60. Neutra, M. R., N. J. Mantis, and J. P. Kraenhenbuhl. 2001. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat. Immunol. 2:1004-1009.
61. Pelto, L., E. Isolauri, E. M. Lilius, J. Nuutila, and S. Salminen. 1998. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 28:1474-1479.
62. Perdigón, G., A. de Moreno de LeBlanc, J. Valdez, and M. Rachid. 2002. Role of yoghurt in the prevention of colon cancer. Eur. J. Clin. Nutr. 56(Suppl. 3):S65-S68.
63. Perdigón, G., C. Maldonado Galdeano, C. G. Vinderola, A. de Moreno, M. Medici, and M. E. Bibas Bonet. 2005. Immunomodulation of mucosal immune response by probiotics. Curr. Trends Immunol. 6:69-85.
64. Perdigón, G., C. Maldonado Galdeano, J. C. Valdez, and M. Medici. 2002. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 56(Suppl. 4):S21-S26.
65. Perdigón, G., M. E. Nader de Macias, S. Alvarez, G. Oliver, and A. A. Pesce de Ruiz Holgado. 1990. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus. J. Dairy Res. 57:255-264.
66. Perdigón, G., M. Medina, E. Vintiñi, and J. C. Valdez. 2001. Intestinal pathway of internalization of lactic acid bacteria and gut mucosal immunostimulation. Int. J. Immunol. Pharmacol. 13:141-150.
67. Perdigón, G., R. Fuller, and M. Medina. 2005. The influence of the lactic acid bacteria and other resident microflora on the immune system of the growing animal, p. 351-375. In W. H. Holzapfel and P. J. Naughton (ed.), Microbial ecology in growing animals. Elsevier Publishing Inc., London, United Kingdom.
68. Perdigón, G., R. Fuller, and R. Raya. 2001. Lactic acid bacteria and their effect on the immune system. Curr. Iss. Intest. Microbiol. 2:27-42.
69. Perdigón, G., S. Alvarez, M. Medina, E. Vintiñi, and E. Roux. 1999. Influence of the oral administration of lactic acid bacteria on IgA producing cells associated to bronchus. Int. J. Immunol. Pharmacol. 12:97-102.
70. Phillips-Quagliata, J. M., M. E. Roux, M. Arny, P. Kelly-Hatfield, M. Mc-Williams, and M. E. Lamm. 1983. Migration and regulation of B cells in the mucosal immune system, p. 194-202. In J. R. McGhee and J. Mestecky (ed.), The secretory immune system. The New York Academy of Science, New York, NY.
71. Raibaud, P. 1992. Bacterial interactions in the gut, p. 9-28. In R. Fuller (ed.), Probiotics. Chapman & Hall, London, England.
72. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229-241.
73. Reddy, B. S. 1999. Possible mechanisms by which pro-and prebiotics influence colon carcinogenesis and tumor growth. J. Nutr. 129:1478S- 1482S.
74. Reid, G., and A. W. Bruce. 2006. Probiotics to prevent urinary tract infections: the rationale and evidence. World J. Urol. 24:28-32.
75. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361-367.
76. Rook, G. A., and L. R. Brunet. 2005. Microbes, immunoregulation and the gut. Gut 54:317-320.
77. Roos, N. M., and M. B. Katan. 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism and carcinogenesis: a review of papers published between 1988 and 1998. Am. J. Clin. Nutr. 71:405-411.
78. Rumbo, M., P. Anderle, A. Didierlaurent, F. Sierra, N. Debard, J. C. Sirard, D. Finke, and J. P. Kraenhenbuhl. 2004. How the gut link innate and adaptative immunity. Ann. N. Y. Acad. Sci. 1029:16-21.
79. Salminen, S., E. Isolauri, and E. Salminen. 1996. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Leeuwenhoek 70:347-358.
80. Schiffrin, E. J., F. Rochat, H. Link-Amster, J. M. Aeschlimann, and A. Donnet-Hughes. 1995. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78:491-497.
81. Schiffrin, E. J., D. Brassart, A. L. Servin, F. Rochat, and A. Donnet-Hughes. 1997. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66:515S-520S.
82. Schultz, M. et al. 2000. Probiotics and inflammatory bowel disease. Am. J. Gastroenterol. 1(Suppl.):S19-S21.
83. Silva, A. M., E. A. Bambirra, A. L. Oliveira, P. P. Souza, D. A. Gomes, E. C. Vieira, and J. R. Nicoli. 1999. Protective effect of bifidus milk on the experimental infection with Salmonella enteritidis subsp. Typhimurium in conventional and gnotobiotic mice. J. Appl. Microbiol. 86:331-336.
84. Simmering, R., B. Kleessen, and M. Blaut. 1999. Quantification of the flavonoid-degrading bacterium Eubacterium ramulus in human fecal samples with a species-specific oligonucleotide hybridization probe. Appl. Environ. Microbiol. 65:3705-3709.
85. Tancrede, C. 1992. Role of human microflora in health and disease. Eur. J. Microbiol. Infect. Dis. 11:1012-1015.
86. Tani, K., K. Kurokawa, and M. Nasu. 1998. Development of a direct in situ PCR method for detection of specific bacteria in natural environments. Appl. Environ. Microbiol. 64:1536-1540.
87. Tuomola, E. M., and S. J. Salminen. 1998. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cells cultures. Int. J. Food Microbiol. 41:45-51.
88. Vaughan, E. E., B. Mollet, and W. M. Vos. 1999. Functionality of probiotics and intestinal lactobacilli: light in the intestinal tract tunnel. Curr. Opin. Biotechnol. 10:505-510.
89. Vinderola, C. G., C. Matar, and G. Perdigón. 2005. Role of the epithelial cells in the immune effects mediated by gram-positive probiotic bacteria. Involvement of Toll-like receptors. Clin. Diagn. Lab. Immunol. 12:1075-1084.
90. Vintiñi, E., S. Alvarez, M. Medina, M. Medici, M. V. de Budeguer, and G. Perdigón. 2000. Gut mucosal immunostimulation by lactic acid bacteria. Biocell 24:223-232.
91. Vintiñi, E., V. Ocaña, and M. E. Nader de Macías. 2004. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains. Methods Mol. Biol. 268:401-410.
92. Yasui, H., K. Shida, T. Matsuzaki, and T. Yokokura. 1999. Immunomodulatory function of lactic acid bacteria. Antonie Leeuwenhoek 76:383-389.